Reaction
Breast Cancer Male reporting signals
As of the last recalculation, Breast Cancer Male appears in 506 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is BICALUTAMIDE (PRR 79.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Bicalutamide | 28 | 79.9 | 80.1 |
| Goserelin | 10 | 31.2 | 31.3 |
| Finasteride | 42 | 31.1 | 31.2 |